why is the fda banning compounded semaglutide moving to restrict mass-marketed GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Safe use of compounded GLP
Description
Beyond their established metabolic effects, emerging research suggests that GLP-1 receptor agonists may possess anti-inflammatory properties
Cardiovasc Diabetol 9: 17
And the published research adds credibility that most competitors lack
We explain how they differ
Digestive symptoms are most common during dose increases and can last a few days to a few weeks
Retatrutide costs vary widely ($400$1,500/month depending on indication and dosing)
